Phio Pharmaceuticals Corp. (PHIO) · INSIDERData sourcesSEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago
Public companyPhio Pharmaceuticals Corp.
PHIOCIK 0001533040
Price$0.80
1 year-49.3%
Disclosed transactions10
Buys / sells7 / 0
Max Insider Score43
Connections with evidence5
PHIO · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 39 | PTPlott Ronald ToddDirector | PHIOPhio Pharmaceuticals Corp. Open-market purchase | BUY | $5,150 5,000 sh | Sep 28, 2026 | Sep 30, 2026 |
| 39 | PTPlott Ronald ToddDirector | PHIOPhio Pharmaceuticals Corp. Open-market purchase | BUY | $5,200 5,000 sh | Sep 29, 2026 | Sep 30, 2026 traded Sep 29, 2026 | +1d | SEC Form 4 | |
| 21 | CCCarson Lisa CabottChief Financial Officer | PHIOPhio Pharmaceuticals Corp. Grant or award | A | — 108.0K sh | Sep 28, 2026 | Sep 29, 2026 traded Sep 28, 2026 | +1d | SEC Form 4 | |
| 17 | BJBitterman Robert JDirector, Chairman, Pres. & CEO | PHIOPhio Pharmaceuticals Corp. Grant or award | A | — 400.0K sh | Sep 28, 2026 | Sep 29, 2026 traded Sep 28, 2026 | +1d | SEC Form 4 | |
| 17 | PTPlott Ronald ToddDirector | PHIOPhio Pharmaceuticals Corp. Grant or award | A | — 17.0K sh | Sep 28, 2026 | Sep 29, 2026 traded Sep 28, 2026 | +1d | SEC Form 4 | |
| 43 | BABradford Patricia ADirector | PHIOPhio Pharmaceuticals Corp. Open-market purchase | BUY | $6,583 6,500 sh | Sep 24, 2026 | Sep 25, 2026 traded Sep 24, 2026 | +1d | SEC Form 4 | |
| 35 | BJBitterman Robert JDirector, Chairman, Pres. & CEO | PHIOPhio Pharmaceuticals Corp. Open-market purchase | BUY | $2,058 2,000 sh | Sep 22, 2026 | Sep 23, 2026 traded Sep 22, 2026 | +1d | SEC Form 4 | |
| 41 | PTPlott Ronald ToddDirector | PHIOPhio Pharmaceuticals Corp. Open-market purchase | BUY | $17K 15.0K sh | Aug 19, 2026 | Aug 20, 2026 traded Aug 19, 2026 | +1d | SEC Form 4 | |
| 25 | BJBitterman Robert JDirector, Chairman, Pres. & CEO | PHIOPhio Pharmaceuticals Corp. Open-market purchase | BUY | $9,900 10.0K sh | Jun 26, 2026 | Jun 29, 2026 traded Jun 26, 2026 | +3d | SEC Form 4 | |
| 35 | BJBitterman Robert JDirector, Chairman, Pres. & CEO | PHIOPhio Pharmaceuticals Corp. Open-market purchase | BUY | $5,100 5,000 sh | Dec 23, 2025 | Dec 29, 2025 traded Dec 23, 2025 | +6d | SEC Form 4 | |
Director, Chairman, Pres. & CEO · Dec 29, 2025